This brief interview with 18-year Abbott veteran, CEO Chris Maynes, outlines what the company expects to achieve from its acquisition of Mayne Pharma.
Bloomberg - (BLOOM)
Mar. 05, 2007. 12:18 PM EST
The Abbott Labs spinoff has been performing well. Its CEO, Chris Begley, discusses its acquisition of Mayne pharma and other high points.